SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Feb 13, 2018
Document Date
Dec 31, 2017
Form Description
Annual filing director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Chinook Therapeutics, Inc.
Issuer
CHINOOK THERAPEUTICS, INC.
Filer
Morningside Venture (VI) Investments Ltd

IR Contact

Novartis Investor Relations

investor.relations@novartis.com

 

MEDIA CONTACT

Novartis Media Relations

media.relations@novartis.com